TrialScientific reports2021

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome.

Jihaeng Im et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.